DRUG · Mapped RxNorm record
valganciclovir
Normalized identity: valganciclovirView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Valganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma
NCT00096538
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedValganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's Sarcoma
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Sarcomaverified · MONDO: sarcoma
Interventions
valganciclovirDRUG · verified · RxNorm: valganciclovir
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
New York Presbyterian Hospitalcollaborator
Weill Medical College of Cornell Universitycollaborator
University of North Carolina, Chapel Hillcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00096538 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.